Fulcrum Equity Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Fulcrum Equity Management's AMGN Position: Q3 2025 in Review
Fulcrum Equity Management sold out of Amgen (AMGN) in Q3 2025, closing a stake of 732 shares — an estimated $204K sold.
Fulcrum Equity Management first reported a position in AMGN in Q4 2018 and held it in 25 quarters. The position peaked at $807K in Q4 2018. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.
- Fulcrum Equity Management reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
- Fulcrum Equity Management sold 732 Amgen shares in Q3 2025, an estimated $204K.
- Fulcrum Equity Management first reported a position in Amgen in Q4 2018 and held it in 25 quarters.
- Fulcrum Equity Management's Amgen position peaked at $807K in Q4 2018.
- 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.
Based on Fulcrum Equity Management's 13F filing for Q3 2025, filed 6 Jan 2026.